Sarepta Therapeutics Zooms Higher on Early Data Rally Promising
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Discover world index performance examples to understand how major benchmarks behave across regions and periods. This primer helps investors compare scales and draw quick insights.
21,743 articlesSarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
A quiet crisis is forming in the real estate lending world. This article explains the $3 trillion challenge, who feel...
Oil markets swing as traders weigh two possible futures depending on how long a conflict will last. The uncertainty i...
Solana and Google Cloud have launched Pay.sh, a pay-as-you-go gateway that enables AI agents to purchase API access w...
Netflix and Meta are trading lower from recent highs, but their risk profiles differ. This piece weighs which merit a...
A cross-border pilot connects Ripple’s XRPL to interbank rails, enabling near real-time settlement of tokenized Treas...
A public moment about a family member sparks online debate and real questions about money, governance, and legacy. He...
SpaceX IPO plans could redefine the space economy, but Blue Origin is positioned to challenge. Learn how to evaluate ...
President Donald Trump plans up to four in-person talks with Xi Jinping within eight months as Air Force One heads to...
As interest rates climb, even active managers recalibrate risk. Advocacy Wealth Management recently trimmed a major P...
Resideo Technologies stock slid after its quarterly update, underscoring how guidance and costs matter as the company...
EnergyX, a Texas-based materials tech firm, has reached a $1B unicorn status after attracting major investors and gov...